If you went past AI Overviews and landed on this page, it means you are looking for insights beyond what AI can provide. Request a sample to get those insights.

Corticosteroids Therapy Market Size & Share Analysis - Growth Trends And Forecast (2025 - 2032)

By Route of Administration;

Inhalation Devices-[Dry Powder, Meter-Dosed Inhalers and Nebulizers], Injections-[Intramuscular and Intravenous], Oral-[Tablets and Suspensions] and Topicals-[Creams, Lotions and Ointments]

By Indication;

Allergic Rhinitis, Asthma, Dermatological Disorders, Inflammatory Bowel Disease and Rheumatoid Arthritis

By Drug Type;

Budesonide, Dexamethasone, Hydrocortisone, Methylprednisolone and Prednisone

By Dosage Form;

Creams, Injections, Suspensions and Tablets

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America
Report ID: Rn346909904 Published Date: September, 2026 Updated Date: November, 2026

Corticosteroids Therapy Market Overview

Corticosteroids Therapy Market (USD BILLION)

Corticosteroids Therapy Market was valued at USD 5.58 billion in the year 2025. The size of this market is expected to increase to USD 7.29 billion by the year 2032, while growing at a Compounded Annual Growth Rate (CAGR) of 3.9%.


Corticosteroids Therapy Market

*Market size in USD Billion

CAGR 3.9 %


Study Period2026 - 2032
Base Year2025
CAGR (%)3.9 %
Market Size (2025)USD 5.58 Billion
Market Size (2032)USD 7.29 Billion
Market ConcentrationHigh
Report Pages300
5.58
2025
7.29
2032

Major Players

  • Pfizer Inc
  • Novartis AG
  • Glaxo Smith Kline GSK plc
  • Merck KGaA
  • Astra Zeneca plc
  • Sanofi SA
  • Cipla Inc
  • Abbott Laboratories
  • Johnson and Johnson
  • Sumitomo Pharma Sumitomo Chemical
*Competitors List Not Exhaustive

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Corticosteroids Therapy Market

Fragmented - Highly competitive market without dominant players


Corticosteroids Therapy Market is expanding steadily as demand rises for effective anti-inflammatory and immunosuppressive treatments. Corticosteroids play a vital role in managing chronic conditions such as asthma, arthritis, and autoimmune disorders, ensuring improved patient outcomes. More than 65% of healthcare providers now recommend advanced corticosteroid therapies, reflecting their critical importance in modern clinical practice.

Key Drivers Accelerating Growth
The rising focus on personalized treatment solutions is a major driver of this market. Nearly 52% of patients are seeking tailored corticosteroid regimens that match their specific health conditions. This demand for precision-based care strengthens the adoption of corticosteroid therapies across hospitals, specialty clinics, and outpatient centers.

Advancements Strengthening Market Adoption
Technological progress in drug formulation and delivery is transforming the market. About 48% of manufacturers are investing in novel inhalers, transdermal systems, and controlled-release formulations. These innovations improve compliance, reduce side effects, and make treatments safer and more effective for long-term use.

Growth Prospects and Industry Outlook
Corticosteroids Therapy Market shows strong growth prospects, supported by stringent regulatory standards that ensure product quality and safety. Nearly 41% of new product approvals emphasize compliance with advanced protocols. With more than 58% of healthcare facilities integrating corticosteroid therapies into chronic disease management, the market is set for continuous expansion.

Corticosteroids Therapy Market Key Takeaways

Corticosteroids Therapy Market Recent Developments

  • In August 2022, a pilot study began examining vamorolone as a potential treatment for Becker muscular dystrophy (BMD), with the first patient receiving a dose of the drug. As part of its research into therapies for various types of muscular dystrophy, ReveraGen BioPharma initiated the development of steroid-based medications aimed at improving patient outcomes.

  • In April 2022, Eli Lilly and Company combined Lebrikizumab with topical corticosteroids to treat atopic dermatitis (AD). In the 16th week of the trial, 75% improvement was observed among patients. These critical combination trials, which met all primary and key secondary objectives, showed that lebrikizumab significantly improved key areas of AD, including skin condition and itch relief.

Corticosteroids Therapy Market Segment Analysis

In this report, Corticosteroids Therapy Market has been segmented by Route of Administration, Indication, Drug Type, Dosage Form, and Geography.

Corticosteroids Therapy Market, Segmentation by Route of Administration

The Route of Administration segment includes Inhalation Devices (Dry Powder, Meter-Dosed Inhalers, and Nebulizers), Injections (Intramuscular and Intravenous), Oral (Tablets and Suspensions), and Topicals (Creams, Lotions, and Ointments). These methods determine how corticosteroids are delivered to patients, impacting both effectiveness and patient preference in treating various conditions.

Inhalation Devices

Inhalation devices such as dry powder inhalers, metered-dose inhalers, and nebulizers are commonly used for treating respiratory conditions like asthma and allergic rhinitis. These devices provide targeted delivery of corticosteroids to the lungs, enhancing treatment effectiveness for pulmonary diseases.

Injections

Injections, including intramuscular and intravenous options, are used for rapid corticosteroid delivery, often for severe inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease. They offer quick systemic effects and are critical in acute disease management.

Oral

Oral corticosteroids in the form of tablets and suspensions are commonly used for chronic conditions like asthma and inflammatory bowel disease. They provide systemic treatment and are easy for patients to administer at home.

Topicals

Topical corticosteroids, available as creams, lotions, and ointments, are primarily used for dermatological disorders. They offer localized treatment for conditions like eczema, psoriasis, and dermatitis, minimizing systemic side effects.

Corticosteroids Therapy Market, Segmentation by Indication

The Indication segment includes Allergic Rhinitis, Asthma, Dermatological Disorders, Inflammatory Bowel Disease, and Rheumatoid Arthritis. These medical conditions represent the primary therapeutic uses of corticosteroids, each benefiting from different delivery methods based on the nature and severity of the condition.

Allergic Rhinitis

Allergic rhinitis is commonly treated with inhalation corticosteroids to reduce inflammation and relieve symptoms such as nasal congestion and sneezing. Inhalers and nasal sprays are often used for targeted treatment of upper airway inflammation.

Asthma

Asthma is frequently managed with inhalation corticosteroids to control airway inflammation and prevent asthma attacks. Both dry powder inhalers and metered-dose inhalers are widely used for long-term management of asthma symptoms.

Dermatological Disorders

Dermatological disorders such as eczema, psoriasis, and dermatitis are treated with topical corticosteroids. These forms of corticosteroids help reduce skin inflammation, itching, and redness, offering relief in chronic skin conditions.

Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is often treated with oral corticosteroids. These medications help control inflammation in the gastrointestinal tract and manage flare-ups of IBD.

Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory condition that benefits from corticosteroid injections (intramuscular or intravenous) and oral corticosteroids. These treatments help manage pain, reduce inflammation, and slow disease progression in affected joints.

Corticosteroids Therapy Market, Segmentation by Drug Type

The Drug Type segment includes Budesonide, Dexamethasone, Hydrocortisone, Methylprednisolone, and Prednisone. These are some of the most widely prescribed corticosteroids, each having different properties and therapeutic uses depending on the severity and condition being treated.

Budesonide

Budesonide is commonly used in the treatment of asthma, allergic rhinitis, and inflammatory bowel disease. It is known for its targeted action in the lungs and gastrointestinal tract, with minimal systemic effects when delivered via inhalation or nebulization.

Dexamethasone

Dexamethasone is a potent corticosteroid used in the treatment of inflammation, autoimmune conditions, and allergies. It is available in multiple forms, including injections and oral formulations, and is often used for acute flare-ups of inflammatory diseases.

Hydrocortisone

Hydrocortisone is one of the most commonly used corticosteroids, often prescribed for conditions such as adrenal insufficiency, dermatitis, and allergic reactions. It is available in various forms, including oral tablets, creams, and injections.

Methylprednisolone

Methylprednisolone is used to treat a wide range of conditions, including autoimmune disorders, allergies, and asthma. It is often administered via oral tablets or injections, offering both immediate and long-term relief from inflammation.

Prednisone

Prednisone is widely used to treat conditions like rheumatoid arthritis, inflammatory bowel disease, and asthma. It is effective in reducing inflammation and controlling flare-ups in chronic conditions, and is often administered orally.

Corticosteroids Therapy Market, Segmentation by Dosage Form

The Dosage Form segment includes Creams, Injections, Suspensions, and Tablets. These dosage forms are selected based on the type of condition being treated and the most effective method of drug delivery for that condition.

Creams

Creams are used for topical treatment of skin conditions such as dermatitis and eczema. These offer localized delivery of corticosteroids, providing targeted relief with minimal systemic side effects.

Injections

Injections are commonly used for rapid systemic relief of inflammation and pain, especially in acute conditions such as rheumatoid arthritis. Injectable corticosteroids provide quick action and are often administered in hospitals or clinics.

Suspensions

Suspensions are used primarily for oral administration in the treatment of diseases such as inflammatory bowel disease and asthma. They allow for easy swallowing and consistent dosing over time.

Tablets

Tablets are commonly used in the oral administration of corticosteroids for long-term management of conditions like rheumatoid arthritis, asthma, and allergies. They offer controlled release and are suitable for chronic conditions requiring consistent medication.

Corticosteroids Therapy Market, Segmentation by Geography

The Geography segment includes North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates corticosteroids therapy market, supported by high healthcare expenditure, extensive research, and a large patient pool. Europe follows closely with increasing adoption of corticosteroid therapies for chronic diseases, while Asia Pacific is witnessing rapid market expansion driven by growing healthcare access and rising prevalence of inflammatory diseases.

Regions and Countries Analyzed in this Report

Legend
North America
Rest of North America
Europe
Rest of Europe
Asia Pacific
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Latin America
Rest of Latin America
Rest of the World

North America

North America leads the corticosteroids therapy market, driven by advanced healthcare infrastructure, a high prevalence of chronic diseases, and widespread adoption of corticosteroid therapies for conditions like asthma, rheumatoid arthritis, and inflammatory bowel disease.

Europe

Europe follows closely, with significant demand for corticosteroids driven by the aging population, increasing awareness of chronic conditions, and strong healthcare systems in countries like Germany, the UK, and France.

Asia Pacific

Asia Pacific is expected to witness rapid growth, fueled by improving healthcare access, increasing prevalence of inflammatory diseases, and rising awareness about the benefits of corticosteroid treatments in countries like China, India, and Japan.

Middle East & Africa

The Middle East & Africa market is expanding, supported by rising healthcare investments and an increasing focus on managing chronic diseases, particularly in countries like the UAE and Saudi Arabia.

Latin America

Latin America is experiencing moderate growth, particularly in Brazil and Mexico, as healthcare access improves and awareness of corticosteroid therapies increases for the management of chronic conditions.

Corticosteroids Therapy Market Forces

This report provides an in depth analysis of various factors that impact the dynamics of Corticosteroids Therapy Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Comprehensive Market Impact Matrix

This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.

Market Forces ↓ / Impact Areas → Market Growth Rate Competitive Landscape Customer Behavior Regulatory Influence Innovation Potential
High impact (e.g., tech adoption, rising demand) Encourages new entrants and fosters expansion Increases usage and enhances demand elasticity Often aligns with progressive policy trends Fuels R&D initiatives and product development
Restraints Slows growth (e.g., high costs, supply chain issues) Raises entry barriers and may drive market consolidation Deters consumption due to friction or low awareness Introduces compliance hurdles and regulatory risks Limits innovation appetite and risk tolerance
Opportunities Unlocks new segments or untapped geographies Creates white space for innovation and M&A Opens new use cases and shifts consumer preferences Policy shifts may offer strategic advantages Sparks disruptive innovation and strategic alliances

Drivers, Restraints and Opportunity Analysis

Drivers :

Restraints :

Opportunities :

Corticosteroids Therapy Market Competitive Landscape Analysis

Corticosteroids Therapy Market is becoming highly competitive as pharmaceutical companies and healthcare providers adopt targeted strategies to expand their therapeutic offerings. With demand rising above 35%, companies are focusing on collaboration, partnerships, and selective merger activities. Continuous innovation in drug delivery systems and biologic corticosteroids is fueling steady growth across autoimmune disorders, asthma, and inflammatory conditions.

Market Structure and Concentration
The market reflects moderate concentration, with nearly 45% share controlled by leading pharmaceutical companies. Larger corporations pursue merger and acquisition strategies to enhance product portfolios, while regional players emphasize niche formulations. This balance sustains competitive growth and supports expansion across both developed and emerging healthcare markets.

Brand and Channel Strategies
Producers are deploying diversified strategies, with more than 40% of corticosteroid therapies distributed through hospitals and pharmacies. Partnerships with healthcare providers, insurers, and government bodies improve accessibility, while branding emphasizes safety, efficacy, and affordability. Digital innovation and regional expansion further reinforce long-term growth and customer engagement.

Innovation Drivers and Technological Advancements
Over 50% of companies are investing in technological advancements such as extended-release formulations, inhalable corticosteroids, and biologic agents. These innovations improve therapeutic outcomes and patient adherence. Strategic partnerships with biotech firms foster growth, while continuous product expansion strengthens competitiveness in advanced therapeutic areas.

Regional Momentum and Expansion
North America holds more than 35% share, supported by a strong healthcare infrastructure and high adoption rates of biologics. Europe contributes above 30%, driven by regulatory frameworks and growing demand for advanced therapies. Asia-Pacific shows rapid growth exceeding 25%, with expansion supported by rising healthcare investments and partnerships with regional healthcare providers.

Future Outlook
The future outlook highlights sustained growth surpassing 40%, driven by the increasing prevalence of autoimmune disorders and asthma. Competitive strategies involving mergers, partnerships, and continuous therapeutic innovation will define the sector. Continued expansion into emerging markets, supported by technological advancements, will ensure long-term competitiveness for corticosteroid therapy providers.

Key players in Corticosteroids Therapy Market include:

In this report, the profile of each market player provides following information:

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Route of Administration
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Drug Type
    4. Market Snapshot, By Dosage Form
    5. Market Snapshot, By Region
  4. Corticosteroids Therapy Market Forces
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Chronic Disease Burden
        2. Expanding Applications in Rheumatology
        3. Advancements in Drug Delivery
      2. Restraints
        1. Side Effects and Long-Term Use Concerns
        2. Regulatory Stringency
      3. Opportunities
        1. Development of Biosimilars
        2. Combination Therapies
        3. Focus on Pediatric Formulations
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Corticosteroids Therapy Market, By Route of Administration, 2022 - 2032 (USD Million)
      1. Inhalation Devices
        1. Dry Powder
        2. Meter-Dosed Inhalers
        3. Nebulizers
      2. Injections
        1. Intramuscular
        2. Intravenous
      3. Oral
        1. Tablets
        2. Suspensions
      4. Topicals
        1. Creams
        2. Lotions
        3. Ointments
    2. Corticosteroids Therapy Market, By Indication, 2022 - 2032 (USD Million)
      1. Allergic Rhinitis
      2. Asthma
      3. Dermatological Disorders
      4. Inflammatory Bowel Disease
      5. Rheumatoid Arthritis
    3. Corticosteroids Therapy Market, By Drug Type, 2022 - 2032 (USD Million)
      1. Budesonide
      2. Dexamethasone
      3. Hydrocortisone
      4. Methylprednisolone
      5. Prednisone
    4. Corticosteroids Therapy Market, By Dosage Form, 2022 - 2032 (USD Million)
      1. Creams
      2. Injections
      3. Suspensions
      4. Tablets
    5. Corticosteroids Therapy Market, By Geography, 2022 - 2032 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Pfizer Inc.
      2. Novartis AG
      3. GlaxoSmithKline
      4. Merck KGaA
      5. AstraZeneca plc
      6. Sanofi SA
      7. Cipla Inc.
      8. Abbott Laboratories
      9. Johnson & Johnson
      10. Sumitomo
      11. Takeda Pharmaceutical Co., Ltd.
      12. Bayer AG
      13. Eli Lilly and Company
      14. Teva Pharmaceutical Industries Ltd.
      15. Fresenius Kabi
  7. Analyst Views
  8. Future Outlook of the Market
Download SampleDownload Sample